Shire Sues Neos To Block Adderall XR Competitor
Irish biopharmaceutical giant Shire PLC lodged its latest bid Thursday to maintain patent protection over the blockbuster attention deficit hyperactivity disorder treatment Adderall XR, suing Neos Therapeutics Inc. in Texas federal...To view the full article, register now.
Already a subscriber? Click here to view full article